share_log

HC Wainwright & Co. Reiterates Buy on Agile Therapeutics, Maintains $12 Price Target

HC Wainwright & Co. Reiterates Buy on Agile Therapeutics, Maintains $12 Price Target

HC Wainwright & Co.重申买入Agile Therapeutics,维持12美元的目标股价
Benzinga ·  2023/06/07 07:00

HC Wainwright & Co. analyst Oren Livnat reiterates Agile Therapeutics (NASDAQ:AGRX) with a Buy and maintains $12 price target.

HC Wainwright & Co. 分析师奥伦·利夫纳特重申Agile Therapeutics(纳斯达克股票代码:AGRX)的买入并维持12美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发